Cleared Traditional

K003112 - VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-H...

K003112 is the FDA 510(k) clearance for VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-H... by Ortho-Clinical Diagnostics, Inc.. It is a Class 1 Microbiology device (product code JJX) cleared through the Traditional 510(k) pathway after a 29-day FDA review.

K003112 · Ortho-Clinical Diagnostics, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2000
Decision
29d
Days
Class 1
Risk

K003112 is an FDA 510(k) clearance for the VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-HBS CONTROLS. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Ortho-Clinical Diagnostics, Inc. (Rochester, US). The FDA issued a Cleared decision on November 2, 2000 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 862.1660 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Ortho-Clinical Diagnostics, Inc. devices

Submission Details

510(k) Number K003112 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 04, 2000
Decision Date November 02, 2000
Days to Decision 29 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
73d faster than avg
Panel avg: 102d · This submission: 29d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 370
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K003112.
ELECSYS HCG+B CALCHECK
K010237 · Roche Diagnostics Corp. · Feb 2001
CA 125 II CALCHECK
K003967 · Roche Diagnostics Corp. · Jan 2001
ELECSYS DHEA-S CALCHECK
K003772 · Roche Diagnostics Corp. · Dec 2000
BIONOSTICS GLUCOSE QUALITY CONTROL SOLUTION FOR USE WITH MEDISENSE BLOOD GLUCOSE TEST STRIP SYSTEMS
K002540 · Bionostics, Inc. · Sep 2000
SUGAR CHEX ONE
K001443 · Streck Laboratories, Inc. · Jun 2000
ELECSYS INSULIN CALCHECK
K001846 · Roche Diagnostics Corp. · Jun 2000